Do you want to be part of the largest gathering of mRNA professionals?

The 2^nd Annual mRNA-Based Therapeutics Summit is returning in-person to Boston this July 26-28.

Expect exclusive data from the movers and shakers in mRNA vaccine and therapy development, 75+ world-class speakers, 5 dedicated tracks of content and 45+ deep-dive case studies. Find out more in the full event guide: https://ter.li/yc800m

Here’s a snapshot of the expert speakers you can hear from:

• ​​​​Kathy Fernando, VP, Head of Worldwide Research, Development and Medical Operations & Head of mRNA Scientific Planning, Pfizer
• Regis Gervier, Global Head, mRNA Center of Excellence, Sanofi
• Rituparna Das, VP – COVID Vaccines, Moderna
• Hao Chen, Global Head of Cell & Viral Drug Substance, GlaxoSmithKline
• Joe Payne, Founder, President & CEO, Arcturus Therapeutics
• Pervin Anklesaria, Deputy Director, HIV Vaccines & Biologics, Bill & Melinda Gates Foundation
• Manmohan Singh, SVP – Pharmaceutical Sciences & Delivery Technologies, Beam Therapeutics
• Akhilesh Bhambhani, Senior Director – Biologics Drug Product Development; Tech Dev/Tech Ops, Ultragenyx
• Liang Shang, Senior Scientist – Vaccine Analytical, Merck
• Russell Johnson, VP – Formulation Research, RVAC Medicines
• Tamar Grossman, Global Head – RNA & Targeted Therapeutics, The Janssen Pharmaceutical Companies of Johnson & Johnson

Download the official brochure to discover why Sanofi, Ultragenyx, Beam Therapeutics, Pfizer, Moderna, Merck, Eli Lilly, GSK, and 300+ others have already secured their places.  https://ter.li/yc800m